• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

信使核糖核酸修饰调控癌症干细胞的命运决定。

mRNA modification orchestrates cancer stem cell fate decisions.

作者信息

Liang Weicheng, Lin Zexiao, Du Cong, Qiu Dongbo, Zhang Qi

机构信息

Vaccine Research Institute, The Third Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, Guangzhou, China.

Guangdong Provincial Key Laboratory of Liver Disease Research, Guangzhou, China.

出版信息

Mol Cancer. 2020 Feb 26;19(1):38. doi: 10.1186/s12943-020-01166-w.

DOI:10.1186/s12943-020-01166-w
PMID:32101138
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7043046/
Abstract

Despite their small numbers, cancer stem cells play a central role in driving cancer cell growth, chemotherapeutic resistance, and distal metastasis. Previous studies mainly focused on how DNA or histone modification determines cell fate in cancer. However, it is still largely unknown how RNA modifications orchestrate cancer cell fate decisions. More than 170 distinct RNA modifications have been identified in the RNA world, while only a few RNA base modifications have been found in mRNA. Growing evidence indicates that three mRNA modifications, inosine, 5-methylcytosine, and N-methyladenosine, are essential for the regulation of spatiotemporal gene expression during cancer stem cell fate transition. Furthermore, transcriptome-wide mapping has found that the aberrant deposition of mRNA modification, which can disrupt the gene regulatory network and lead to uncontrollable cancer cell growth, is widespread across different cancers. In this review, we try to summarize the recent advances of these three mRNA modifications in maintaining the stemness of cancer stem cells and discuss the underlying molecular mechanisms, which will shed light on the development of novel therapeutic approaches for eradicating cancer stem cells.

摘要

尽管癌症干细胞数量较少,但在驱动癌细胞生长、化疗耐药和远处转移方面发挥着核心作用。以往的研究主要集中在DNA或组蛋白修饰如何决定癌症中的细胞命运。然而,RNA修饰如何协调癌细胞命运决定在很大程度上仍不清楚。在RNA世界中已鉴定出170多种不同的RNA修饰,而在mRNA中仅发现了少数几种RNA碱基修饰。越来越多的证据表明,三种mRNA修饰,即肌苷、5-甲基胞嘧啶和N-甲基腺苷,对于癌症干细胞命运转变过程中的时空基因表达调控至关重要。此外,全转录组图谱分析发现,mRNA修饰的异常沉积可破坏基因调控网络并导致癌细胞生长失控,在不同癌症中广泛存在。在本综述中,我们试图总结这三种mRNA修饰在维持癌症干细胞干性方面的最新进展,并讨论其潜在的分子机制,这将为开发根除癌症干细胞的新型治疗方法提供线索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f8/7043046/8ed54d59562f/12943_2020_1166_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f8/7043046/b99188f56c62/12943_2020_1166_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f8/7043046/2717254d5cce/12943_2020_1166_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f8/7043046/8ed54d59562f/12943_2020_1166_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f8/7043046/b99188f56c62/12943_2020_1166_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f8/7043046/2717254d5cce/12943_2020_1166_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91f8/7043046/8ed54d59562f/12943_2020_1166_Fig3_HTML.jpg

相似文献

1
mRNA modification orchestrates cancer stem cell fate decisions.信使核糖核酸修饰调控癌症干细胞的命运决定。
Mol Cancer. 2020 Feb 26;19(1):38. doi: 10.1186/s12943-020-01166-w.
2
Epigenetic Modifications of mRNA and DNA in Plants.植物中 mRNA 和 DNA 的表观遗传修饰。
Mol Plant. 2020 Jan 6;13(1):14-30. doi: 10.1016/j.molp.2019.12.007. Epub 2019 Dec 18.
3
Novel insight into the regulatory roles of diverse RNA modifications: Re-defining the bridge between transcription and translation.深入了解多种 RNA 修饰的调控作用:重新定义转录和翻译之间的桥梁。
Mol Cancer. 2020 Apr 17;19(1):78. doi: 10.1186/s12943-020-01194-6.
4
Roles and implications of mRNA N -methyladenosine in cancer.mRNA N6 -甲基腺苷在癌症中的作用和意义。
Cancer Commun (Lond). 2023 Jul;43(7):729-748. doi: 10.1002/cac2.12458. Epub 2023 Jun 23.
5
mA Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer.mA 修饰在编码和非编码 RNA 中的作用及其在癌症中的治疗意义。
Cancer Cell. 2020 Mar 16;37(3):270-288. doi: 10.1016/j.ccell.2020.02.004.
6
RNA Modifications in Cancer Stem Cell Biology.RNA 修饰在癌症干细胞生物学中的作用。
Cancer Treat Res. 2023;190:25-47. doi: 10.1007/978-3-031-45654-1_2.
7
Cell Fate Control by Translation: mRNA Translation Initiation as a Therapeutic Target for Cancer Development and Stem Cell Fate Control.通过翻译控制细胞命运:mRNA 翻译起始作为癌症发展和干细胞命运控制的治疗靶点。
Biomolecules. 2019 Oct 29;9(11):665. doi: 10.3390/biom9110665.
8
mA RNA Modification Determines Cell Fate by Regulating mRNA Degradation.mA RNA修饰通过调控mRNA降解决定细胞命运。
Cell Reprogram. 2017 Aug;19(4):225-231. doi: 10.1089/cell.2016.0041. Epub 2017 Jul 6.
9
RNA methylation in mammalian development and cancer.哺乳动物发育和癌症中的 RNA 甲基化。
Cell Biol Toxicol. 2021 Dec;37(6):811-831. doi: 10.1007/s10565-021-09627-8. Epub 2021 Jul 17.
10
Advances in the profiling of N-methyladenosine (mA) modifications.m6A 修饰谱分析的研究进展。
Biotechnol Adv. 2020 Dec;45:107656. doi: 10.1016/j.biotechadv.2020.107656. Epub 2020 Nov 9.

引用本文的文献

1
Aging increases susceptibility to liver fibrosis through enhanced NAT10-mediated ac4C modification of TGFβ1 mRNA.衰老通过增强NAT10介导的TGFβ1 mRNA的ac4C修饰增加了对肝纤维化的易感性。
Genome Med. 2025 Aug 15;17(1):90. doi: 10.1186/s13073-025-01520-x.
2
Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance.将表观遗传调节因子作为克服癌症治疗耐药性的一条有前景的途径。
Signal Transduct Target Ther. 2025 Jul 18;10(1):219. doi: 10.1038/s41392-025-02266-z.
3
Phosphoproteomics Reveals L1CAM-Associated Signaling Networks in High-Grade Serous Ovarian Carcinoma: Implications for Radioresistance and Tumorigenesis.

本文引用的文献

1
Reading, writing and erasing mRNA methylation.阅读、书写和擦除 mRNA 甲基化。
Nat Rev Mol Cell Biol. 2019 Oct;20(10):608-624. doi: 10.1038/s41580-019-0168-5. Epub 2019 Sep 13.
2
Regulation of Co-transcriptional Pre-mRNA Splicing by mA through the Low-Complexity Protein hnRNPG.mA 通过低复杂度蛋白 hnRNPG 调控共转录前体 mRNA 的剪接。
Mol Cell. 2019 Oct 3;76(1):70-81.e9. doi: 10.1016/j.molcel.2019.07.005. Epub 2019 Aug 21.
3
Epitranscriptomic Addition of mC to HIV-1 Transcripts Regulates Viral Gene Expression.mC 修饰在 HIV-1 转录本中的添加调控病毒基因表达。
磷酸化蛋白质组学揭示高级别浆液性卵巢癌中与L1细胞粘附分子相关的信号网络:对放射抗性和肿瘤发生的影响
Int J Mol Sci. 2025 May 10;26(10):4585. doi: 10.3390/ijms26104585.
4
NAT10-mediated N4-acetylcytidine modification in KLF9 mRNA promotes adipogenesis.NAT10介导的KLF9 mRNA中的N4-乙酰胞苷修饰促进脂肪生成。
Cell Death Differ. 2025 Mar 23. doi: 10.1038/s41418-025-01483-x.
5
ADAMTS12 serves as a novel prognostic biomarker and promotes proliferation and invasion in gastric cancer.ADAMTS12作为一种新的预后生物标志物,促进胃癌的增殖和侵袭。
Discov Oncol. 2024 Dec 25;15(1):837. doi: 10.1007/s12672-024-01724-4.
6
Comprehensive review of drug resistance in mammalian cancer stem cells: implications for cancer therapy.哺乳动物癌症干细胞耐药性的综合综述:对癌症治疗的启示
Cancer Cell Int. 2024 Dec 18;24(1):406. doi: 10.1186/s12935-024-03558-0.
7
Targeting treatment resistance: unveiling the potential of RNA methylation regulators and TG-101,209 in pan-cancer neoadjuvant therapy.靶向治疗抵抗:揭示 RNA 甲基化调节剂和 TG-101,209 在泛癌新辅助治疗中的潜力。
J Exp Clin Cancer Res. 2024 Aug 19;43(1):232. doi: 10.1186/s13046-024-03111-x.
8
A mA regulators-related classifier for prognosis and tumor microenvironment characterization in hepatocellular carcinoma.一个与 mA 调节剂相关的分类器,用于预测肝细胞癌的预后和肿瘤微环境特征。
Front Immunol. 2024 Jul 25;15:1374465. doi: 10.3389/fimmu.2024.1374465. eCollection 2024.
9
RNA 5-methylcytosine regulates YBX2-dependent liquid-liquid phase separation.RNA 5-甲基胞嘧啶调节YBX2依赖性液-液相分离。
Fundam Res. 2021 Dec 8;2(1):48-55. doi: 10.1016/j.fmre.2021.10.008. eCollection 2022 Jan.
10
Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy.用于癌症免疫治疗的免疫特异性和肿瘤依赖性mRNA疫苗:将临床转化重新编程为肿瘤编辑疗法。
Pharmaceutics. 2024 Mar 25;16(4):455. doi: 10.3390/pharmaceutics16040455.
Cell Host Microbe. 2019 Aug 14;26(2):217-227.e6. doi: 10.1016/j.chom.2019.07.005.
4
RNA 5-Methylcytosine Facilitates the Maternal-to-Zygotic Transition by Preventing Maternal mRNA Decay.RNA 5-甲基胞嘧啶通过防止母体 mRNA 降解促进母源到合子的过渡。
Mol Cell. 2019 Sep 19;75(6):1188-1202.e11. doi: 10.1016/j.molcel.2019.06.033. Epub 2019 Aug 6.
5
5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs.5-甲基胞嘧啶通过稳定 mRNA 促进膀胱癌的发病机制。
Nat Cell Biol. 2019 Aug;21(8):978-990. doi: 10.1038/s41556-019-0361-y. Epub 2019 Jul 29.
6
Nuclear hnRNPA2B1 initiates and amplifies the innate immune response to DNA viruses.核 hnRNPA2B1 启动并放大了对 DNA 病毒的固有免疫反应。
Science. 2019 Aug 16;365(6454). doi: 10.1126/science.aav0758. Epub 2019 Jul 18.
7
Single-base mapping of mA by an antibody-independent method.单碱基 mA 的抗体非依赖方法作图。
Sci Adv. 2019 Jul 3;5(7):eaax0250. doi: 10.1126/sciadv.aax0250. eCollection 2019 Jul.
8
RNA modifications regulating cell fate in cancer.RNA 修饰调控癌症中的细胞命运。
Nat Cell Biol. 2019 May;21(5):552-559. doi: 10.1038/s41556-019-0319-0. Epub 2019 May 2.
9
Regulation of Gene Expression by N-methyladenosine in Cancer.N6-甲基腺苷在癌症中对基因表达的调控。
Trends Cell Biol. 2019 Jun;29(6):487-499. doi: 10.1016/j.tcb.2019.02.008. Epub 2019 Mar 30.
10
Cancer stem cell self-renewal as a therapeutic target in human oral cancer.癌症干细胞自我更新作为人类口腔癌的治疗靶点。
Oncogene. 2019 Jul;38(27):5440-5456. doi: 10.1038/s41388-019-0800-z. Epub 2019 Apr 1.